SWRP
SRPT icon

Summit Wealth & Retirement Planning’s Sarepta Therapeutics SRPT Stock Holding History

Summit Wealth & Retirement Planning’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,986
Closed -$549K – 102
2023
Q1 		$549K Sell
3,986
-1,857
-32% -$241K 0.21% 47
2022
Q4 		$757K Hold
5,843
– – 0.31% 38
2022
Q3 		$646K Buy
5,843
+1,115
+24% +$112K 0.26% 49
2022
Q2 		$354K Sell
4,728
-57
-1% -$4.19K 0.14% 85
2022
Q1 		$374K Sell
4,785
-243
-5% -$18.6K 0.13% 79
2021
Q4 		$453K Buy
5,028
+2,699
+116% +$231K 0.15% 66
2021
Q3 		$215K Buy
+2,329
New +$179K 0.08% 81
2021
Q2 		– Sell
-3,125
Closed -$233K – 97
2021
Q1 		$233K Sell
3,125
-2,067
-40% -$191K 0.09% 91
2020
Q4 		$885K Buy
5,192
+37
+0.7% +$5.48K 0.34% 55
2020
Q3 		$724K Sell
5,155
-191
-4% -$29K 0.31% 59
2020
Q2 		$857K Sell
5,346
-2,387
-31% -$325K 0.4% 52
2020
Q1 		$756K Buy
7,733
+685
+10% +$78.3K 0.4% 52
2019
Q4 		$909K Buy
7,048
+1,006
+17% +$102K 0.4% 49
2019
Q3 		$455K Sell
6,042
-20
-0.3% -$2.36K 0.27% 78
2019
Q2 		$921K Sell
6,062
-130
-2% -$15.8K 0.54% 46
2019
Q1 		$738K Sell
6,192
-4,131
-40% -$531K 0.44% 57
2018
Q4 		$1.13M Buy
+10,323
New +$1.29M 0.85% 30

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Wealth & Retirement Planning's SRPT Position: Q2 2023 in Review

Summit Wealth & Retirement Planning sold out of Sarepta Therapeutics (SRPT) in Q2 2023, closing a stake of 3,986 shares — an estimated $549K sold.

Summit Wealth & Retirement Planning first reported a position in SRPT in Q4 2018 and held it in 17 quarters. The position peaked at $1.13M in Q4 2018. 404 funds tracked by Wall St. Rank hold SRPT as of Q2 2023.

  • Summit Wealth & Retirement Planning reported no remaining Sarepta Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Summit Wealth & Retirement Planning sold 3,986 Sarepta Therapeutics shares in Q2 2023, an estimated $549K.
  • Summit Wealth & Retirement Planning first reported a position in Sarepta Therapeutics in Q4 2018 and held it in 17 quarters.
  • Summit Wealth & Retirement Planning's Sarepta Therapeutics position peaked at $1.13M in Q4 2018.
  • 404 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2023.

Based on Summit Wealth & Retirement Planning's 13F filing for Q2 2023, filed 26 Jul 2023.